Time is running out to secure this ASX healthcare share dividend

Investors only have until the end of trading today to get hold of the latest Virtus Health dividend.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Virtus Health shares are edging into the red this afternoon
  • The company's shares are due to trade ex-dividend tomorrow
  • Eligible shareholders will receive a dividend payment of 12 cents per share on 14 April

The Virtus Health Ltd (ASX: VRT) share price is seesawing today. It has been down as low as $8.21 and as high as $8.27 but it is currently 0.12% in the red at $8.22.

This comes despite the fertility treatment company not releasing any price-sensitive announcements to the ASX today.

In comparison, the All Ordinaries Index (ASX: XAO) has shot up 1.17% to 7,647.6 points today.

So what's been happening with Virtus Health?

A man points at a paper as he holds an alarm clock, indicating the ex-dividend date is approaching.

Image source: Getty Images

Virtus Health shares set to go ex-dividend

Today is the last chance for investors to get their hands on the Virtus Health interim dividend.

Investors need to buy Virtus Health shares before market close today to be eligible for the interim dividend. The ex-dividend date is tomorrow, Wednesday 23 March.

It is worth noting that on the ex-dividend day, the share price traditionally falls in proportion to the dividend amount. This is because investors tend to sell off the company's shares after securing the dividend.

What does this mean for Virtus Health shareholders?

For those who are eligible for the Virtus Health interim dividend, shareholders will receive a payment of 12 cents per share on 14 April.

The dividend is also fully franked, which means shareholders can expect to receive tax credits from this.

Virtus Health share price summary

When looking at the past 12 months, the Virtus Health share price is up almost 40%. It is also up 20% this year to date.

The company's shares reached a 52-week high of $8.33 a little over a week ago. This came after the company announced it had signed a transaction implementation deed with an entity controlled by CapVest Partners. Under the deed, CapVest will acquire 100% of Virtus shares by a scheme of arrangement. 

Based on today's price, Virtus Health commands a market capitalisation of roughly $703.97 million and has a trailing dividend yield of 2.92%.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Female scientist working in a laboratory.
Healthcare Shares

This ASX biotech stock could deliver 40%-plus returns Morgans says

This small company continues to kick goals.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Healthcare Shares

How high could Cochlear shares bounce back? Brokers disagree

Despite bad news on the earnings front this week, Cochlear shares could still deliver upside.

Read more »

Retired couple hugging and laughing.
Healthcare Shares

A Budget announcement has put a rocket under this ASX aged care provider's shares

A shake up in the funding model will be a boost for this company.

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

What on earth's going on with Pro Medicus shares?

The quality stock is now driven heavily by expectations.

Read more »

A stressed businessman sits next to his briefcase with his head in his hands, while the ASX boards behind him show shares crashing.
52-Week Lows

CSL's collapse deepens. Why this ASX giant can't find a floor

CSL shares hit a 9-year low as new demand concerns emerge.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Prediction: CSL shares could surpass $265 in 2026

CSL shares are tumbling again on Wednesday. Here's what it'll take for the price to take a u-turn.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

Why are Cochlear shares down 36% today?

The medical device manufacturer has delivered a bitter pill for shareholders.

Read more »